Efficacy and safety of glucagon‐like peptide‐1/glucagon receptor co‐agonist JNJ ‐64565111 in individuals with type 2 diabetes mellitus and obesity: A randomized dose‐ranging study-Reference-Cited by-同舟云学术

Efficacy and safety of glucagon‐like peptide‐1/glucagon receptor co‐agonist JNJ ‐64565111 in individuals with type 2 diabetes mellitus and obesity: A randomized dose‐ranging study

Published:2021-01-21 Issue:2 Volume:11 Page:
ISSN:1758-8103
Container-title:Clinical Obesity
language:en
Short-container-title:Clin Obes

Author:

Di Prospero Nicholas A.¹^ORCID,Yee Jaqueline¹,Frustaci Mary E.²,Samtani Mahesh N.¹,Alba Maria¹,Fleck Penny¹^ORCID

Affiliation:

1. Janssen Research & Development, LLC Raritan New Jersey USA

2. Janssen Research & Development, LLC Spring House Pennsylvania USA

Funder

Janssen Research and Development

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cob.12433

Reference49 articles.

1. Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories

2. Obesity and insulin resistance

3. Obesity, Fat Distribution, and Weight Gain as Risk Factors for Clinical Diabetes in Men

4. Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults

5. World Health Organization.Obesity and overweight;2020. Available at:https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Accessed February 20 2020.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Efficacy of Novel Incretin Co-agonist Cotadutide in Biopsy-proven Noncirrhotic MASH With Fibrosis;Clinical Gastroenterology and Hepatology;2024-09

2. GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review;eClinicalMedicine;2024-09

3. Incretin-based therapy: a new horizon in diabetes management;Journal of Diabetes & Metabolic Disorders;2024-08-17

4. The role of incretin receptor agonists in the treatment of obesity;Diabetes, Obesity and Metabolism;2024-07-29

5. The Efficacy of Pharmacotherapy in the Treatment of Obesity in Patients With Type 2 Diabetes: A Systematic Review;Cureus;2024-07-24